Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Bawat – Presentation of Q4 2022 interim report

By Michael FriisHead of Equities
Bawat Water Technologies
Today, Bawat announced its Q4 2022 report. We have interviewed Bawat’s CEO Marcus Peter Hummer to get an update on the results and hear more about the expectations for 2023.

Looking at highlights from the report and the interview, Bawat has already announced its 2022 order intake in mid-January of SEK 18.1m (full-year guidance was SEK 35-50m). Delays in decision-making with two large clients implied that Bawat reached an order intake of SEK 1.2m in Q4 2022. However, Bawat now reports that a large order for a mobile unit has been confirmed in February 2023, and the second large order for mobile units is still in commercial negotiations.

Focusing on the market, quoting activity remains at a high level and reached a record level of more than SEK 75m in Q4 2022. Bawat still sees a higher interest from potential customers, despite that the company experiences longer sales periods than expected from initial contact to the decision of an actual order on its Mobile Solutions.

For the full year 2023, Bawat’s guidance is an order intake in the range of SEK 40-60m. EBITDA is estimated to reach break-even in H2 2024.

Read the full report here: https://view.news.eu.nasdaq.com/view?id=bc5dfb511fc1f1792e4a39310f2945956&lang=en

Disclaimer: HC Andersen Capital receives payment from Bawat for a DigitalIR/Corporate Visibility agreement. /Michael Friis 17:30, 21 February 2023.

Recent videos

A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-11 11:00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
2025-12-10 12:30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
2025-12-10 09:00 Clas Ohlson
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-09 22:11 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.